European Journal Of Health Economics web
Pontos Posição
CEF.UP+NIPE (average of all rankings) (2012) 14.75 311/501
Australian RC (2010) 50.0 324/479
CNRS (2008) 40.0 170/336
Ideas discounted recursive impact factor (2012) 0.14 365/396
ISI, JCR SSE, Impact Factor (2010) 23.61 72/388
Schneider and Ursprung (2008) 20.0 204/278
Source Normalized Impact per Paper (SNIP) (2011) 8.51 303/476
Article Influence Score (2021) 1.12 167/409
Article Influence Score (2019) 0.84 185/428
Impact Factor (2021) 5.27 62/409
Impact Factor (2019) 2.37 117/440
Impact Factor (5 year) (2021) 4.13 116/409
Impact Factor (5 year) (2019) 2.53 149/428
SJR - Scimago (2021) 0.87 231/558
SJR - Scimago (2019) 0.96 214/549
Count (2021) 1.0 155/652
Artigos 26:

HIT-6 and EQ-5D-5L in Patients with Migraine: Assessment of Common Latent Constructs and Development of a Mapping Algorithm
Ana Sofia Oliveira Goncalves, Dimitra Panteli, Lars Neeb, Tobias Kurth, Annette Aigner
vol. 23, 2022, p. 47-57.

Pharmaceutical Pricing Dynamics in an Internal Reference Pricing System: Evidence from Changing Drugs' Reimbursements
Eduardo Costa, Carolina Santos
vol. 23, 2022, p. 1497-1518.

Survival Analysis of Cancer Patients in Portugal following the Reference Centre Model Implementation
Manuel Melo Mateus, Margarida Catalão Lopes, Rui Portugal
vol. , 2022, p. .

The Impact of Cancellations in Waiting Times Analysis: Evidence from Scheduled Surgeries in the Portuguese NHS
Joana Cima, Alvaro Almeida
vol. 23, 2022, p. 95-104.

Does Waiting Time Decrease or Increase Operational Costs in Short and Long-Term? Evidence from Portuguese Public Hospitals
André Madeira, Victor Moutinho, Jose A. Fuinhas
vol. 22, 2021, p. 1195-1216.

Does waiting times decrease or increase operational costs in short and long-term? Evidence from Portuguese public hospitals.
André Madeira, Victor Moutinho, Jose A. Fuinhas
vol. 22, 2021, p. 1195-1216.

Multi-layer Health Insurance Coverage, Medical Services Use and Health in a Universal National Health System, the Case of Portugal
Aida Isabel Tavares, Ines Marques
vol. 22, 2021, p. 141-153.

Advanced Therapy Medicinal Products: Value Judgement and Ethical Evaluation in Health Technology Assessment
Elisabete Goncalves
vol. 21, 2020, p. 311-320.

Multi-criteria Decision Analysis for Health Technology Assessment: Addressing Methodological Challenges to Improve the State of the Art
Monica Duarte Oliveira, Ines Mataloto, Panos Kanavos
vol. 20, 2019, p. 891-918.

Junior Doctors' Medical Specialty and Practice Location Choice: Simulating Policies to Overcome Regional Inequalities
Pedro Ramos, Hélio Alves, Paulo Guimarães, Maria A. Ferreira
vol. 18, 2017, p. 1013-1030.

The Place of DPP-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: A Systematic Review of Cost-Effectiveness Studies
Alexandre Baptista, Inês Teixeira, Sonia Romano, Antonio Vaz Carneiro, Julian Perelman
vol. 18, 2017, p. 937-965.

The Economic Impact of Chronic Pain: A Nationwide Population-Based Cost-of-Illness Study in Portugal
Luis Filipe Azevedo, Altamiro Costa-Pereira, Liliane Mendonca, Claudia Camila Dias, José M. Castro-Lopes
vol. 17, 2016, p. 87-98.

Demand Uncertainty and Hospital Costs: An Application to Portuguese Public Hospitals
Alvaro Almeida, Joana Ferreira Cima
vol. 16, 2015, p. 35-45.

Did the Corporatization of Portuguese Hospitals Significantly Change Their Productivity?
Diogo Ferreira, Rui Cunha Marques
vol. 16, 2015, p. 289-303.

SF-6D Portuguese Population Norms
Pedro Augusto Ferreira, Lara N Ferreira, Luis Nobre Pereira
vol. 16, 2015, p. 235-241.

Cost-Effectiveness of Lung Transplantation and Its Evolution: The Portuguese Case
Luís Mendonça, Julian Perelman, Vanessa Rodrigues, José Fragata
vol. 15, 2014, p. 767-772.

Cost Effects of Hospital Mergers in Portugal
Helda Azevedo, Céu Mateus
vol. 15, 2014, p. 999-1010.

Does Health Promote Economic Growth? Portuguese Case Study: From Dictatorship to Full Democracy
Sónia Maria Aniceto Morgado
vol. 15, 2014, p. 591-598.

Analysis of HIV/AIDS DRG in Portugal: A Hierarchical Finite Mixture Model
Sara Simões Dias, Valeska Andreozzi, Rosário O. Martins
vol. 14, 2013, p. 715-723.

Patients` Access to Biologics in Rheumatoid Arthritis: A Comparison between Portugal and Other European Countries
Pedro A. Laires, F. Exposto, Rui Mesquita, Ana P. Martins, Luís Cunha-Miranda, João Eurico Fonseca
vol. 14, 2013, p. 875-885.

Colorectal Cancer in Portugal
Carlos Gouveia Pinto, Ana Teresa Paquete, Irene Pissarra
vol. 10, 2010, p. 65-73.

Geographic Distribution of Physicians in Portugal
Isabel Correia, Paula Veiga
vol. 11, 2010, p. 383-393.

The Challenge of Corporatisation: The Experience of Portuguese Public Hospitals
Guilhermina Rego, Rui Nunes, José Costa
vol. 11, 2010, p. 367-381.

Contractual Design and PPPs for Hospitals: Lessons for the Portuguese Model
Pedro Pita Barros, Xavier Martinez-Giralt
vol. 10, 2009, p. 437-453.

Substance Abuse Treatment, What Do We Know? An Economist´s Perspective
Matilde Machado
vol. 6, 2005, p. 53-64.

Pricing and Reimbursement of Pharmaceuticals in Portugal
Carlos Gouveia Pinto, Inês Teixeira
vol. 3, 2002, p. 267-270.